- Myricitin', "3,3',4',5,5',7-Hexahydroxyflavone", "3,5,7,3',4',5'-Hexahydroxyflavone", '3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
- Lopac0_000740
- NCI60_003870
- NCGC00015697-04
- Myricetin - CAS 529-44-2
- Myricetin, >=96.0%, crystalline
- KBio2_001981
- Myricetin (Standard)
- NCGC00015697-14
- STL284709', "3,7,3',4',5'-Hexahydroxyflavone", 'AKOS015903103
- NSC-407290
- BSPBio_000570
- 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-
- NCGC00094083-04
- Myricetin (Cannabiscetin)
- 3,3′,4′,5,5′,7-Hexahydroxyflavone
- 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one
- Myricetin, analytical standard
- SCHEMBL19302
- myricetin
- SMR001233193
- DivK1c_006627
- HMS1569M12
- NCGC00015697-10
- cid_5281672
- EU-0100740
- 529-44-2
- NCGC00015697-11
- 4gqr
- CCG-204825
- NCGC00015697-08
- NCGC00015697-06
- NCGC00015697-13
- SR-01000076005
- KS-5268
- DA-65734
- 3,4,5-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-7-one
- REGID_for_CID_5281672
- NSC 407290
- BPBio1_000628
- NSC407290
- Tox21_500740
- UNII-76XC01FTOJ
- 2o63
- Myricetin, >=96.0% (HPLC)
- SR-01000076005-1
- MLS006010718
- BCP28295
- CHEMBL164', "FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY-", 'Myricetin from Myrica cerifera leaf and bark
- SDCCGSBI-0050718.P008', "3,3',4',5,5',7-hexOH-Flavone", "Flavone,3',4',5,5',7-hexahydroxy-", 'NCGC00015697-01
- NCGC00094083-01
- Q-100601
- SW196616-2
- Cannabiscetin; HSDB 7682; HSDB7682; HSDB-7682
- MEGxp0_000357
- S00115', "3,3',4',5,5',7-hexahydroxy-(8CI)- flavone", 'Q951449
- Myricetol
- HMS2231L04
- Prestwick3_000465
- BRD-K43149758-001-04-5
- Myrc
- M 6760
- MYRICETIN [HSDB]
- KBio2_004549
- 76XC01FTOJ
- NCGC00094083-02
- delphidenolon 1575
- BIDD:PXR0079
- C07E0ED2-ABF6-4BD3-A2B2-A98CAEF20FD1
- Prestwick0_000465
- 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one
- Spectrum5_000692
- LP00740
- SR-01000076005-6
- BDBM15236
- DB02375
- NCGC00015697-02
- SY051702
- NCGC00179517-02
- CAS-529-44-2
- 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-
- CCRIS 5838
- BRD-K43149758-001-22-7
- NCGC00261425-01
- HMS3262C22
- Spectrum_001501
- NCGC00015697-05
- HSDB 7682
- MYRICETIN [MI]
- SpecPlus_000531
- Spectrum4_001272
- LMPK12110001
- SDCCGSBI-0050718.P003
- NCGC00015697-09
- HMS2096M12
- HY-15097R
- DTXSID8022400
- C15H10O8
- CHEBI:18152
- M2131
- BRD-K43149758-001-23-5
- 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one #
- NCGC00015697-07
- Lopac-M-6760
- Cannabiscetin
- Prestwick2_000465
- NCGC00015697-03
- ACon1_000267
- HMS3656I05
- KBioGR_001884
- CS-6221
- HY-15097
- BIDD:ER0142
- CHEBI: 18152
- EINECS 208-463-2
- NCGC00015697-12
- NCGC00015697-25
- Prestwick_342
- MLS002153825
- NCGC00179517-01
- HB0434
- Myricetin, primary pharmaceutical reference standard
- KBio2_007117
- TNP00286
- KBioSS_001981
- MFCD00006827', "3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one", 'BRN 0332331
- Prestwick1_000465
- NCGC00094083-03
- Myricetin
- AC-4533
- SPBio_002509
- GTPL13074
- KBio1_001571
- NS00014642
|
